Erytech Pharma - ADR

NASDAQ:ERYP  
7.01
+0.26 (+3.89%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)188.30M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.38 Million
Adjusted EPS-$0.94
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Erytech Pharma - ADR Stock, NASDAQ:ERYP

B?¢timent Ad?©nine, 60, avenue Rockefeller, Lyon, Auvergne-Rhone-Alpes 69008
France
Phone: +33.4.78.74.44.38
Number of Employees: 206

Description

ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France.